PALI-2108 is the first and only PDE4 inhibitor designed to target terminal ileum and colon for fibrostenotic Crohn’s disease (FSCD) and ulcerative colitis (UC) to address significant unmet medical ...

There was high-level energy at GSX 2025, befitting an industry undergoing massive change. Artificial intelligence (AI) was ...